Document is current
Any future updates will be listed below
-
Authors
Torres, Marcelo D. T. https://orcid.org/0000-0002-6165-9138
Wan, Fangping
de la Fuente-Nunez, Cesar https://orcid.org/0000-0002-2005-5629
-
Funding
Funding for this research was provided by:
United States Department of Defense | Defense Threat Reduction Agency (HDTRA1-23-1-0001)
- License Information
-
More Information
Article History
Received: 20 December 2024
Accepted: 16 June 2025
First Online: 12 August 2025
Competing interests
: C.d.l.F.-N. is a co-founder and scientific advisor to Peptaris Inc., provides consulting services to Invaio Sciences and is a member of the scientific advisory boards of Nowture S.L., Peptidus and Phare Bio. C.d.l.F.-N. is also on the advisory board of the Peptide Drug Hunting Consortium (PDHC). The de la Fuente Lab has received research funding or in-kind donations from United Therapeutics, Strata Manufacturing PJSC and Procter & Gamble, none of which were used in support of this work. M.D.T.T. is a co-founder and scientific advisor to Peptaris, Inc. The other author declares no competing interests.
